Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued

"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges

from NDTV Profit - Latest https://ift.tt/3yDfsYf
"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges

Comments

Popular posts from this blog

RBI Vs Government: Finance Ministry To Shortly Issue A Statement

भारत-चीन की लड़ाई पहुंची बंदरगाहों पर! चीनी समान की हो रही है बारीकी से जांच